Use of antidepressants with pharmacogenetic prescribing guidelines in a 10-year depression cohort of adult primary care patients
Conclusion
One-quarter of primary care patients used an antidepressant that was not recommended for them based on CYP2D6- and CYP2C19-based prescribing guidelines and switching medications tended to be more common in this group. Studies to determine the impact of CYP2D6 and CYP2C19 genotyping on reducing gene-antidepressant mismatches are warranted.
Source: Pharmacogenetics and Genomics - Category: Genetics & Stem Cells Tags: Original Articles Source Type: research
More News: Amitriptyline | Celexa | Citalopram | Depression | Doxepin | Effexor | Genetics | Imipramine | Lexapro | Nortriptyline | Paroxetine | Paxil | Primary Care | Sertraline | Study | Zoloft